Teva links with Kowa to enter Japan market - updated
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industrieshas struck an alliance with Kowa to set up an equally owned joint venture in Japan, which is to develop and market a range of generic products with a focus on those from the Israeli company's portfolio.